Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Association of baseline inflammatory biomarkers and clinical outcomes in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitors.
Journal: Therapeutic advances in medical oncology
Published: August 28, 2024
Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah's witness: A case report.
Journal: Frontiers in oncology
Published: May 20, 2022
Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience.
Journal: Journal of immunotherapy and precision oncology
Published: January 06, 2022
Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma.
Journal: The oncologist
Published: November 15, 2021
Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients.
Journal: Clinical genitourinary cancer
Published: June 09, 2021
Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors.
Journal: Frontiers in oncology
Published: May 08, 2021
Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade.
Journal: Frontiers in oncology
Published: April 27, 2021
Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Journal: The oncologist
Published: April 09, 2021
Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib.
Journal: Cancer treatment and research communications
Published: March 29, 2021
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors.
Journal: The oncologist
Published: February 18, 2021
Symptomatic methemoglobinemia in a patient with metastatic clear cell renal cell carcinoma treated with pembrolizumab and axitinib combination therapy: a case report.
Journal: Journal of medical case reports
Published: September 18, 2020
Last Updated: 09/26/2026